Rights and permissions
About this article
Cite this article
Statins poor contenders for OTC status, says expert. Pharmacoecon. Outcomes News 476, 2 (2005). https://doi.org/10.2165/00151234-200504760-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504760-00002